Limei Wang
Impact in
- Pollution top 2%
- Pharmaceutical and Antibiotic Environmental Impacts
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Advanced biosensing and bioanalysis techniques 11
- RNA Interference and Gene Delivery 9
- Gene expression and cancer classification 7
- Bioinformatics and Genomic Networks 7
- Immunology 26
- Co-authors
- Bingjie Xu (1 shared paper)Daqing Mao (1 shared paper)Lin Xu (1 shared paper)Yi Luo (1 shared paper)Yong Cheng (5 shared papers)Bin Qi (7 shared papers)Xiuliang Zhao (5 shared papers)Denise L. Faustman (1 shared paper)
- Journals
- Molecules (7 papers)Scientific Reports (5 papers)Ceramics International (4 papers)International Immunopharmacology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Limei Wang
220 papers receiving 4.9k citations
Limei Wang's Hit Papers
Peers
Comparison fields: 5 of 168
- Pollution 565
- Molecular Medicine 221
- Immunology 654
- Molecular Biology 1.8k
- Cancer Research 287
Countries citing papers authored by Limei Wang
This map shows the geographic impact of Limei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Wang more than expected).
Fields of papers citing papers by Limei Wang
This network shows the impact of papers produced by Limei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Wang. The network helps show where Limei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment Hit paper breakdown → | 2012 | 593 |
| 2 | 2015 | 151 | |
| 3 | 2013 | 146 | |
| 4 | 2007 | 144 | |
| 5 | Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. | 2004 | 125 |
| 6 | 2021 | 120 | |
| 7 | 2017 | 108 | |
| 8 | 2008 | 97 | |
| 9 | 2020 | 93 | |
| 10 | 2023 | 89 | |
| 11 | 2020 | 81 | |
| 12 | 2022 | 78 | |
| 13 | 2022 | 77 | |
| 14 | 2015 | 65 | |
| 15 | 2008 | 61 | |
| 16 | 2015 | 59 | |
| 17 | 2015 | 56 | |
| 18 | 2019 | 56 | |
| 19 | 2015 | 53 | |
| 20 | 2012 | 52 |
About Limei Wang
Limei Wang is a scholar working on Molecular Biology, Immunology, Plant Science, Oncology and Mechanical Engineering, having authored 233 papers that have together received 4.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (11 papers), RNA Interference and Gene Delivery (9 papers), Advanced materials and composites (8 papers), Gene expression and cancer classification (7 papers), Advanced ceramic materials synthesis (7 papers), Bioinformatics and Genomic Networks (7 papers), Cancer-related molecular mechanisms research (6 papers) and Advanced machining processes and optimization (6 papers). The work is most often cited by research in Pollution (565 citations), Molecular Medicine (221 citations), Immunology (654 citations), Molecular Biology (1.8k citations) and Cancer Research (287 citations). Limei Wang has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Bingjie Xu, Daqing Mao, Lin Xu, Yi Luo, Yong Cheng, Bin Qi, Xiuliang Zhao, Denise L. Faustman, Toshiyuki Mera and Yoshiaki Okubo. Their work appears in journals such as Molecules, Scientific Reports, Ceramics International, International Immunopharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.